Tissue Regenix
The company develops and manufactures regenerative medicine products using proprietary dCELL and BioRinse technology platforms to process human and porcine tissue. Its portfolio includes allografts and xenografts for musculoskeletal, dermis, and soft tissue applications, such as the OrthoPure XT Ligament Reconstruction Implant. These products are distributed to hospitals, medical professionals, and distribution partners for use in surgical procedures and patient care.
Healthtech
Medical Technology
Biotechnology
Regenerative Medicine
Funding summary
- Total raised
- €16.7M
- Funding rounds
- 1
Investors in Tissue Regenix
Investors on record for Tissue Regenix. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Tissue Regenix?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors